Atrovent Hfa

— THERAPEUTIC CATEGORIES —
  • Asthma/COPD

Atrovent Hfa Generic Name & Formulations

General Description

Ipratropium bromide 17micrograms/inh; metered dose inhaler; CFC-free.

Pharmacological Class

Anticholinergic.

How Supplied

Inhaler—12.9g (200 inh); inhalation soln—contact supplier

Generic Availability

HFA (NO); soln (YES)

Atrovent Hfa Indications

Indications

Bronchospasm associated with chronic bronchitis and emphysema.

Atrovent Hfa Dosage and Administration

Adult

2 inh 4 times daily; max 12 inh/day.

Children

Not established.

Atrovent Hfa Contraindications

Contraindications

Allergy to atropine or its derivatives.

Atrovent Hfa Boxed Warnings

Not Applicable

Atrovent Hfa Warnings/Precautions

Warnings/Precautions

Not for primary treatment of acute attack. Avoid eyes. Narrow-angle glaucoma. GU obstruction. Pregnancy. Nursing mothers.

Atrovent Hfa Pharmacokinetics

See Literature

Atrovent Hfa Interactions

Interactions

Caution with other anticholinergics.

Atrovent Hfa Adverse Reactions

Adverse Reactions

Bronchitis, COPD exacerbation, dyspnea, headache, anticholinergic effects; paradoxical bronchospasm, hypersensitivity reactions.

Atrovent Hfa Clinical Trials

See Literature

Atrovent Hfa Note

Not Applicable

Atrovent Hfa Patient Counseling

See Literature